Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MCI Conversion to Dementia”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Not applicableStudy completedNCT03824197
What this trial is testing

Auburn University Research on Olive Oil for Alzheimer's Disease (AU-ROOAD)

Who this might be right for
Alzheimer DiseaseCerebral Amyloid Angiopathy
Auburn University 25
Not applicableNot Yet RecruitingNCT05310890
What this trial is testing

Long Term Prospective Study of Tai Chi Intervention to Prevent MCI From Conversion to Dementia

Who this might be right for
Mild Cognitive Impairment
Ruijin Hospital 206
Not applicableUnknownNCT01436552
What this trial is testing

Psychopathological Risk Factors Associated With Conversion From Mild Cognitive Impairment to Dementia

Who this might be right for
Mild Cognitive Impairment
Centre Hospitalier Esquirol 392
Not applicableStudy completedNCT01823666
What this trial is testing

Predicting the Conversion From Mild Cognitive Impairment to Dementia

Who this might be right for
Mild Cognitive ImpairmentAlzheimer DiseaseDementia, Vascular
Dongzhimen Hospital, Beijing 250
Not applicableLooking for participantsNCT07701161
What this trial is testing

Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device

Who this might be right for
Alzheimer s DiseaseMCI Conversion to DementiapTau217+1 more
Neurogen Biomarking LLC 1,000
Not applicableStudy completedNCT03448445
What this trial is testing

Evaluate Alzheimer's Disease Conversion Rate Differences Between High-risk Mild Cognitive Impairment (MCI) and Low-risk MCI in a Real World Setting

Who this might be right for
Mild Cognitive Impairment
Eisai Korea Inc. 201
Testing effectiveness (Phase 2)Study completedNCT02491268
What this trial is testing

A Trial of Cilostazol in Patients With Mild Cognitive Impairment (COMCID)

Who this might be right for
Mild Cognitive Impairment
National Cerebral and Cardiovascular Center, Japan 166
Not applicableLooking for participantsNCT07272811
What this trial is testing

Neurocognitive Assessment Platform 4 Alzheimer

Who this might be right for
MCIMCI Conversion to DementiaAMCI - Amnestic Mild Cognitive Impairment+1 more
IRCCS San Raffaele 100
Not applicableLooking for participantsNCT05697588
What this trial is testing

Exploring the Predicting Biomarkers From Mild Cognitive Impairment to Dementia (EBMID)

Who this might be right for
BiomarkersMCI Conversion to Dementia
Cuibai Wei，Clinical Professor 900
Not applicableStudy completedNCT07630688
What this trial is testing

Validation and Reliability of the Turkish Version of the Montreal Cognitive Assessment-Basic (MoCA-B) in Individuals With Low Educational Level

Who this might be right for
Behavioral and Psychological Symptoms of DementiaDementiaDementia (Diagnosis)+6 more
Antalya Training and Research Hospital 166
Testing effectiveness (Phase 2)Study completedNCT01429623
What this trial is testing

A 3 Year Study to Evaluate the Safety and Efficacy of Low Dose Ladostigil in Patients With Mild Cognitive Impairment

Who this might be right for
Mild Cognitive ImpairmentDementia
Avraham Pharmaceuticals Ltd 210